Abstract
Peptide deformylase (PDF) is a ubiquitous bacterial metalloenzyme responsible to cleave the formyl group from nascent polypeptides, supporting in the maturation. It plays a vital role in the survival of bacterial cells which is conserved in the eubacteria and is considered to be an attractive target for developing new antibacterial agents. Homology modeling was employed for generation of 3-D structure of PDF of M. tuberculosis H37Rv and showed 92.5% amino acid in the allowed region of Ramachandran plot. PDF was used as target for a set of inhibitors with substantial structural differences. Docking results show that the BB-3497, BBS-54, Actinonin and BBS-02 bind with high affinity to enzyme active site. Phylogeny of PDF in M. tuberculosis H37Rv shows homology with other strains of pathogenic bacteria. These data validate PDF as a novel target for the design of a new generation of antimycobacterial agents.
Keywords: Mycobacterium tuberculosis, Peptide deformylase, Docking, Phylogeny, Drugs
Letters in Drug Design & Discovery
Title: Targeting the Peptide Deformylase of Mycobacterium tuberculosis Leads to Drug Discovery
Volume: 6 Issue: 7
Author(s): Vijai Singh and Pallavi Somvanshi
Affiliation:
Keywords: Mycobacterium tuberculosis, Peptide deformylase, Docking, Phylogeny, Drugs
Abstract: Peptide deformylase (PDF) is a ubiquitous bacterial metalloenzyme responsible to cleave the formyl group from nascent polypeptides, supporting in the maturation. It plays a vital role in the survival of bacterial cells which is conserved in the eubacteria and is considered to be an attractive target for developing new antibacterial agents. Homology modeling was employed for generation of 3-D structure of PDF of M. tuberculosis H37Rv and showed 92.5% amino acid in the allowed region of Ramachandran plot. PDF was used as target for a set of inhibitors with substantial structural differences. Docking results show that the BB-3497, BBS-54, Actinonin and BBS-02 bind with high affinity to enzyme active site. Phylogeny of PDF in M. tuberculosis H37Rv shows homology with other strains of pathogenic bacteria. These data validate PDF as a novel target for the design of a new generation of antimycobacterial agents.
Export Options
About this article
Cite this article as:
Singh Vijai and Somvanshi Pallavi, Targeting the Peptide Deformylase of Mycobacterium tuberculosis Leads to Drug Discovery, Letters in Drug Design & Discovery 2009; 6 (7) . https://dx.doi.org/10.2174/157018009789108286
DOI https://dx.doi.org/10.2174/157018009789108286 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding
Current Topics in Medicinal Chemistry Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period
Recent Patents on Anti-Infective Drug Discovery A Key Role for Altered Dendritic Cell Functioning in the Impaired Immunity Seen in Aged Individuals
Current Immunology Reviews (Discontinued) Recent Developments in Antitubercular Drugs
Mini-Reviews in Medicinal Chemistry Molecular Dissection of Renal Ischemia-Reperfusion: Oxidative Stress and Cellular Events
Current Medicinal Chemistry Editorial [Hot Topic: Looking Beyond the Obvious: Search for Novel Targets and Drugs for Reducing the Burden of Infectious Diseases (Guest Editor: Neelima Arora)]
Mini-Reviews in Medicinal Chemistry Editorial: [A Threat to One is a Threat to All – Biosecurity for the Western World Starts in Developing Countries: Do We Speak the Same Language of Hygiene?]
Inflammation & Allergy - Drug Targets (Discontinued) Pharmaceutical Care: Past, Present and Future
Current Pharmaceutical Design New Chemotherapy and Immunotherapy for Tuberculosis
Current Respiratory Medicine Reviews Vitamin D and Metabolic Syndrome: Is There a Link?
Current Pharmaceutical Design Non-Antidepressant Treatment of Social Anxiety Disorder: A Review
Current Clinical Pharmacology NMDA Pathology and Treatment of Schizophrenia
Current Pharmaceutical Design Impact of Mast Cell Chymase on Renal Disease Progression
Current Hypertension Reviews Xenicane Natural Products: Biological Activity and Total Synthesis
Current Pharmaceutical Design Editorial (Thematic Issue: <i>In Silico</i> Drug Design and Medicinal Chemistry)
Current Topics in Medicinal Chemistry Structural Basis for Inhibition of Enoyl-[Acyl Carrier Protein] Reductase (InhA) from Mycobacterium tuberculosis
Current Medicinal Chemistry Oxazolidinone-containing Hybrids with Antibacterial Activity against Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA): A Mini-review
Current Topics in Medicinal Chemistry Microbial Immune Evasion Employing Suppressor of Cytokine Signaling (SOCS) Proteins
Inflammation & Allergy - Drug Targets (Discontinued) Synthesis of Novel Aryl (4-Aryl-1H-Pyrrol-3-yl) (Thiophen-2-yl) Methanone Derivatives: Molecular Modelling, In Silico ADMET, Anti-Inflammatory and Anti-Ulcer Activities
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Therapeutic Potential of Plant Extracts and Phytochemicals Against Brain Ischemia-Reperfusion Injury: A Review
The Natural Products Journal